What does Royalcare Super Speciality Hospital do?

Royalcare Super Speciality Hospital Limited is a quaternary care hospital group in Coimbatore, Tamil Nadu. Incorporated in 2012 and commencing operations in 2015 as a 50-bed facility, the hospital offers high-complexity super speciality treatments including cardiac care, neurosciences, oncology, and organ transplantation. The hospital has expanded significantly since inception.

Is Royalcare planning an IPO?

No formal IPO announcement has been made by Royalcare Super Speciality Hospital Limited as of mid-2025. The company continues to operate as an unlisted entity.

What specialties does Royalcare Hospital offer?

Royalcare Super Speciality Hospital offers quaternary and super speciality services including cardiology, cardiac surgery, neurology, neurosurgery, oncology, orthopedics, organ transplantation, and critical care. The hospital is positioned as a high-acuity care provider in the Coimbatore region.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Royalcare Super Speciality Hospital Limited?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Royalcare Super Speciality Hospital Limited shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Royalcare Super Speciality Hospital Limited Unlisted Share Price | Buy Royalcare Super Speciality Hospital Limited Pre-IPO Shares — wisefolio

Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Talk to us

Royalcare Super Speciality Hospital Limited Unlisted Share Price | Buy Royalcare Super Speciality Hospital Limited Pre-IPO Shares — wisefolio | wisefolio

Pros

750-bed ultra-modern super-specialty hospital at Neelambur, Coimbatore; Phase 1: 300 beds (Nov 2016); oncology, cardiology, critical care, neurosciences — comprehensive super-specialty coverage.
Revenue ₹338 Cr (FY2023-24); 8.78% growth; profit +56.18% — strong profitability improvement; ISIN INE02C801010; authorized ₹250 Cr; paid-up ₹204.91 Cr — well capitalised.
Promoters: Dr. K. Chockalingam (cardiologist, ~30 yrs experience) + neurosurgeon + P.K. Alagesan (businessman) — clinician-led governance with business expertise; Coimbatore — South India's major healthcare hub.
Website: royalcarehospital.in; royalcareneurosciences.com; Infomerics rated (Nov 2024) — professional credit rating for NBFC/bond compliance.

Cons

Unlisted (U-prefix) — no secondary market despite ISIN INE02C801010; revenue ₹100-500 Cr range (FY2025) — revenue bracket not narrowed.
Large hospital capex with ₹250 Cr authorized capital; debt levels not confirmed but 750-bed facility implies significant borrowings.
Coimbatore healthcare market: competition from established chains (Kovai Medical Center, PSG Hospitals, Ramakrishna Hospital).
Incorporated 2012 — 13 years old; still expanding (750-bed full capacity not yet reached per 2016 Phase 1 data).

Business Segments

Super-Specialty Hospital

750-bed ultra-modern super-specialty hospital; oncology, cardiology, critical care, neurosciences; Neelambur, Coimbatore, Tamil Nadu; royalcarehospital.in; royalcareneurosciences.com.

Revenue Model

Royalcare generates revenue through inpatient and outpatient hospital services, with high-value quaternary procedures (cardiac surgery, neurosurgery, organ transplants) forming the revenue backbone. Additional revenue streams include diagnostics, pharmacy, and medical tourism from patients in Kerala and Karnataka seeking specialized care in Coimbatore.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds8

Growth Plans

Rising incidence of lifestyle diseases (cardiac, oncology) in Tamil Nadu increasing demand for super speciality hospital services

Coimbatore's growing reputation as a medical tourism destination attracting patients from Kerala, Karnataka, and even internationally

Government's Ayushman Bharat empanelment providing access to a larger insured patient pool

Industry Tailwinds

Recent Developments

Revenue ₹338 Cr; profit +56.18%

Royalcare Super Speciality Hospital reported revenue of ₹338 Cr (FY2023-24); 8.78% revenue growth; 56.18% profit increase — strong operational leverage from maturing hospital capacity.

FY2023-24

Infomerics credit rating

Infomerics Valuation and Rating issued credit rating for Royalcare Super Speciality Hospital Limited — November 25, 2024.

November 2024

Phase 1 (300 beds) inaugurated

300-bed Phase 1 of the 750-bed Neelambur, Coimbatore super-specialty hospital inaugurated; cardiology, oncology, critical care, neurosciences departments operational.

November 2016

Comparable Companies

CompanyTypeTickerMkt Cap

Kovai Medical Centre and HospitalListedKAMARAJAR~2500 Cr

Apollo HospitalsListedAPOLLOHOSP~95000 Cr

Fortis HealthcareListedFORTIS~30000 Cr

Kovai Medical Centre and HospitalListed

KAMARAJAR · ~2500 Cr

Frequently Asked Questions

About Royalcare Super Speciality Hospital Limited

Royalcare Super Speciality Hospital Limited is a Coimbatore-based quaternary care hospital group incorporated in 2012, commencing operations in 2015 as a 50-bed facility. The company rapidly expanded to a 750-bed flagship campus at Neelambur, Coimbatore in 2016 and now operates approximately 1,100 total beds with over 2,000 healthcare professionals. Royalcare offers quaternary-level care across cardiology, neurology, oncology, orthopaedics, and organ transplantation among other specialties. In FY2024, the company reported revenues of Rs. 338 Cr (8.78% YoY growth) with a net profit margin of approximately 7.36%. However, FY2025 saw margin compression to approximately 4.27% due to expansion-related costs. The hospital is actively traded in the pre-IPO market as an unlisted company. Founded by Dr. K. Madeswaran (neurosurgeon) and Dr. K. Chockalingam (cardiologist), Royalcare has built a strong reputation in South India for complex surgeries and critical care. The company faces financial pressure from aggressive capacity expansion and high debt servicing costs relative to its scale.

Key Milestones

Incorporated December 4, 2012 in Tamil Nadu (CIN: U85100TZ2012PLC018984) — Coimbatore

Promoters: Dr. K. Chockalingam (cardiologist) + neurosurgeon + P.K. Alagesan (businessman)

Common questions about unlisted shares

How do I buy Royalcare Super Speciality Hospital Limited unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Royalcare Super Speciality Hospital Limited

How settlement works

Get price alerts for Royalcare Super Speciality Hospital Limited

Discuss Royalcare Super Speciality Hospital Limited

Similar companies

Other ways to invest